ONC - Latest News

BeOne Medicines AG (ONC), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $37.30B. Trailing twelve-month P/E ratio is 79.19. Beta to the broader market is 0.52.

The article list below shows the most recent ONC headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent ONC Headlines

Comparing Aurora Cannabis (NASDAQ:ACB) & BeOne Medicines (NASDAQ:ONC)

defenseworld.net - Oct 12, 2026

BeOne Medicines (NASDAQ: ONC - Get Free Report) and Aurora Cannabis (NASDAQ: ACB - Get Free Report) are both healthcare companies, but which is the be

Oncolytics Biotech (TSE:ONC) Share Price Crosses Below 200 Day Moving Average – Here’s Why

defenseworld.net - Oct 6, 2026

Oncolytics Biotech Inc. (TSE: ONC - Get Free Report)'s stock price crossed below its 200-day moving average during trading on Monday.

Biotech Leader BeOne Medicines Poised To Hit Early Buy Points

investors.com - Oct 1, 2026

Biotech leader BeOne stock is poised to hit multiple buy points. Its blockbuster drug generated $1.

BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Stock Has Consensus Target Price of $402.71

defenseworld.net - Oct 1, 2026

BeOne Medicines Ltd. - Sponsored ADR (NASDAQ: ONC - Get Free Report) has earned a consensus recommendation of "Buy" from the seventeen ratings firms

Head-To-Head Analysis: BeOne Medicines (NASDAQ:ONC) versus NRx Pharmaceuticals (NASDAQ:NRXP)

defenseworld.net - Sep 28, 2026

NRx Pharmaceuticals (NASDAQ: NRXP - Get Free Report) and BeOne Medicines (NASDAQ: ONC - Get Free Report) are both healthcare companies, but which is t

How News Affects ONC Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track ONC's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked ONC news questions

What is the latest ONC news headline?

The most recent ONC headline (Oct 12, 2026) is "Comparing Aurora Cannabis (NASDAQ:ACB) & BeOne Medicines (NASDAQ:ONC)". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the ONC news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What ONC news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual ONC options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.